Toll-like receptors are potential therapeutic targets in rheumatoid arthritis

doi:10.4331/wjbc.v2.i7.167

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4642)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

390

HTML

3902

Figures (1-1)

198

Tables (1-1)

152

Sum=4642

Jul 26, 2011 (publication date) through May 26, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Biol Chem. Jul 26, 2011; 2(7): 167-172
Published online Jul 26, 2011. doi: 10.4331/wjbc.v2.i7.167

Open in New Tab Full Size Figure Download Figure

Figure 1 The Toll-like receptor signaling pathway. The ligands of Toll-like receptors, their signaling adaptors and downstream mediators are depicted. LPS: Lipopolysaccharide; HSP: Heat shock protein; TLR: Toll-like receptor; IRAK: Interleukin-1 receptor-associated kinase.

Citation: Shotorbani SS, Su ZL, Xu HX. Toll-like receptors are potential therapeutic targets in rheumatoid arthritis. World J Biol Chem 2011; 2(7): 167-172
URL: https://www.wjgnet.com/1949-8454/full/v2/i7/167.htm
DOI: https://dx.doi.org/10.4331/wjbc.v2.i7.167